Hologic (HOLX)
(Delayed Data from NSDQ)
$79.86 USD
-1.35 (-1.66%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $79.88 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
- YR Estimate
- 09/30/2023
- 09/30/2022
- 09/30/2021
- 09/30/2020
- 09/30/2019
- Revenue - Line of Business (LOBR)
- Revenues: Diagnostics: Cytology and Perinatal
- 480.60
- 474.70
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Revenues: Diagnostics: Molecular Diagnostics
- 1,361.70
- 2,511.40
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Revenues: Diagnostics: Blood Screening
- 37.80
- 32.40
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Revenue: Total Diagnostics
- 1,880.10
- 3,018.50
- 3,695.00
- 2,102.10
- 1,205.50
- Revenue - Line of Business (LOBR)
- Revenues: Breast Health: Breast Imaging
- 1,144.20
- 951.60
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Revenues: Breast Health: Interventional Breast Solutions
- 288.50
- 276.20
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Revenue: Total Breast Health
- 1,432.70
- 1,227.80
- 1,352.30
- 1,151.90
- 1,314.20
- Revenue - Line of Business (LOBR)
- Revenue: GYN Surgical
- 604.20
- 521.40
- 488.10
- 376.10
- 437.20
- Revenue - Line of Business (LOBR)
- Revenue: Skeletal Health
- 113.40
- 93.60
- 96.90
- 81.00
- 94.80
- Revenue - Line of Business (LOBR)
- Revenues: Product Sales
- 3,279.90
- 4,191.20
- 4,967.30
- 3,227.00
- 2,771.30
- Revenue - Line of Business (LOBR)
- Revenues: Service and other revenue
- 750.50
- 671.60
- 665.00
- 549.40
- 596.00
- Revenue - Geographic (GEOR)
- Revenue: United States
- 3,058.00
- 3,467.90
- 3,902.30
- 2,863.20
- 2,536.00
- Revenue - Geographic (GEOR)
- Revenue: Europe
- 520.30
- 888.50
- 1,201.80
- 569.80
- 396.00
- Revenue - Geographic (GEOR)
- Revenue: Asia-Pacific
- 255.70
- 359.70
- 365.00
- 226.80
- 286.00
- Revenue - Geographic (GEOR)
- Revenue: Rest of World
- 196.40
- 146.70
- 163.20
- 116.60
- 149.30